Inhibition of angiogenesis by vitamin D3 analogues
- 1 March 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 178 (2), 247-250
- https://doi.org/10.1016/0014-2999(90)90483-m
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A SYNTHETIC ANALOGUE OF VITAMIN D3, 22-OXA-lα,25-DIHYDROXYVITAMIN D3IS A POTENT MODULATOR OF IN VIVO IMMUNOREGULATING ACTIVITY WITHOUT INDUCING HYPERCALCEMIA IN MICEEndocrinology, 1989
- Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic).The Journal of Antibiotics, 1989
- Tumor-promoting phorbol esters induce angiogenesis in vivoAmerican Journal of Physiology-Cell Physiology, 1988
- Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemiaFEBS Letters, 1987
- Molecular Cloning of Complementary DNA Encoding the Avian Receptor for Vitamin DScience, 1987
- Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus.Molecular and Cellular Biology, 1986
- Tumor AngiogenesisAdvances in Cancer Research, 1985
- Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells.Journal of Biological Chemistry, 1984